EGFR and lung cancer: The method was validated for detection of the <i>EGFR</i> L858R mutation in patients with nonsmall cell lung cancer, yielding an excellent linear calibration curve (r = 0.9981), recovery rates of 95-110%, and a detection limit of 2.33%.